Clinical TrialsSearch results
Number of results: 287
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- A Phase II study of docetaxel (T) and cyclophosphamide(C) as adjuvant chemotherapy for patients with high risk, node negative, early stage breast cancer
- Breast cancer
- Japan East Cancer Center Breast Cancer Consortium
- 2006-10-01
Other
- A Phase II Study of Trastuzumab plus S-1 in Patients with Advanced or Recurrent HER2 positive Breast Cancer
- Breast cancer
- Gunma Breast Clinical Conference Study Group(GBCCSG)
- 2008-10-01
Other
- Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.
- Breast cancer
- Gunma Breast Cancer Research Group 2 surgery
- 2009-08-31
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06
Other
- Randomized controlled trial on effectiveness of ultrasonography in breast cancer screening(Japan Strategic Anti-Cancer Randomized Trial)
- Breast Cancer
- Division of Surgical Oncology, Graduate School of Medicine, TOHOKU UNIVERSITY
- 2007-07-01
Other
- Study of Advanced life support for Ventricular fibrillation with Extracorporeal circulation in Japan
- Cardiopulmonary arrest on arrival(CPAOA)
- Teikyo University School of Medicine, Teikyo University Hospital
- 2008-10-01
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04